REFERENCES

• 1. Goulet JA, Senunas LE, DeSilva GL, Greenfield ML. Autogenous iliac crest bone graft. Complications and functional assessment. Clin Orthop Relat Res, 1997;(339):76-81.Article
• 2. Greenwald AS, Boden SD, Goldberg VM, et al. Bone-graft substitutes: facts, fictions, and applications. J Bone Joint Surg Am, 2001;83:Suppl 2 Pt 2. 98-103.Article
• 3. Campana V, Milano G, Pagano E, et al. Bone substitutes in orthopaedic surgery: from basic science to clinical practice. J Mater Sci Mater Med, 2014;25:2445-2461.ArticlePDF
• 4. Moshiri A, Oryan A. Role of tissue engineering in tendon reconstructive surgery and regenerative medicine: current concepts, approaches and concerns. Hard Tissue, 2012;1:11. Article
• 5. Garg NK, Gaur S, Sharma S. Percutaneous autogenous bone marrow grafting in 20 cases of ununited fracture. Acta Orthop Scand, 1993;64:671-672.Article
• 6. Connolly J, Guse R, Lippiello L, Dehne R. Development of an osteogenic bone-marrow preparation. J Bone Joint Surg Am, 1989;71:684-691.Article
• 7. Connolly JF. Injectable bone marrow preparations to stimulate osteogenic repair. Clin Orthop Relat Res, 1995;(313):8-18.
• 8. Ross R, Raines EW, Bowen-Pope DF. The biology of plateletderived growth factor. Cell, 1986;46:155-169.Article
• 9. Kitoh H, Kawasumi M, Kaneko H, Ishiguro N. Differential effects of culture-expanded bone marrow cells on the regeneration of bone between the femoral and the tibial lengthenings. J Pediatr Orthop, 2009;29:643-649.Article
• 10. Manyalich M, Navarro A, Koller J, et al. European quality system for tissue banking. Transplant Proc, 2009;41:2035-2043.Article
• 11. Shigeyama Y, D'Errico JA, Stone R, Somerman MJ. Commercially-prepared allograft material has biological activity in vitro. J Periodontol, 1995;66:478-487.
• 12. Tomford WW. Transmission of disease through transplantation of musculoskeletal allografts. J Bone Joint Surg Am, 1995;77:1742-1754.Article
• 13. Lohmann CH, Andreacchio D, Köster G, et al. Tissue response and osteoinduction of human bone grafts in vivo. Arch Orthop Trauma Surg, 2001;121:583-590.ArticlePDF
• 14. Hamer AJ, Strachan JR, Black MM, Ibbotson CJ, Stockley I, Elson RA. Biomechanical properties of cortical allograft bone using a new method of bone strength measurement. A comparison of fresh, fresh-frozen and irradiated bone. J Bone Joint Surg Br, 1996;78:363-368.
• 15. Stevenson S, Emery SE, Goldberg VM. Factors affecting bone graft incorporation. Clin Orthop Relat Res, 1996;(324):66-74.Article
• 16. Sandhu HS, Grewal HS, Parvataneni H. Bone grafting for spinal fusion. Orthop Clin North Am, 1999;30:685-698.Article
• 17. Enneking WF, Campanacci DA. Retrieved human allografts: a clinicopathological study. J Bone Joint Surg Am, 2001;83:971-986.
• 18. Finkemeier CG. Bone-grafting and bone-graft substitutes. J Bone Joint Surg Am, 2002;84:454-464.
• 19. Ullmark G, Obrant KJ. Histology of impacted bone-graft incorporation. J Arthroplasty, 2002;17:150-157.Article
• 20. Lane JM. Bone morphogenic protein science and studies. J Orthop Trauma, 2005;19:S17-S22.Article
• 21. Grabowski G, Cornett CA. Bone graft and bone graft substitutes in spine surgery: current concepts and controversies. J Am Acad Orthop Surg, 2013;21:51-60.Article
• 22. Wildemann B, Kadow-Romacker A, Pruss A, Haas NP, Schmidmaier G. Quantification of growth factors in allogenic bone grafts extracted with three different methods. Cell Tissue Bank, 2007;8:107-114.
• 23. Niederauer GG, Lee DR, Sankaran S. Bone grafting in arthroscopy and sports medicine. Sports Med Arthrosc, 2006;14:163-168.Article
• 24. Kinney RC, Ziran BH, Hirshorn K, Schlatterer D, Ganey T. Demineralized bone matrix for fracture healing: fact or fiction? J Orthop Trauma, 2010;24:Suppl 1. S52-S55.Article
• 25. Blokhuis TJ, Arts JJ. Bioactive and osteoinductive bone graft substitutes: definitions, facts and myths. Injury, 2011;42:Suppl 2. S26-S29.Article
• 26. Parikh SN. Bone graft substitutes in modern orthopedics. Orthopedics, 2002;25:1301-1309. quiz 1310-1311.
• 27. Moore DC, Chapman MW, Manske D. The evaluation of a biphasic calcium phosphate ceramic for use in grafting long-bone diaphyseal defects. J Orthop Res, 1987;5:356-365.
• 28. Zwingenberger S, Nich C, Valladares RD, Yao Z, Stiehler M, Goodman SB. Recommendations and considerations for the use of biologics in orthopedic surgery. BioDrugs, 2012;26:245-256.
• 29. Tay BK, Patel VV, Bradford DS. Calcium sulfate- and calcium phosphate-based bone substitutes. Mimicry of the mineral phase of bone. Orthop Clin North Am, 1999;30:615-623.
• 30. Urist MR. Bone: formation by autoinduction. Science, 1965;150:893-899.
• 31. Bishop GB, Einhorn TA. Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery. Int Orthop, 2007;31:721-727.
• 32. Slosar PJ, Josey R, Reynolds J. Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes. Spine J, 2007;7:301-307.
• 33. Govender S, Csimma C, Genant HK, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am, 2002;84:2123-2134.
• 34. Friedlaender GE, Perry CR, Cole JD, et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am, 2001;83:Suppl 1. S151-S158.
• 35. Baas J, Elmengaard B, Jensen TB, Jakobsen T, Andersen NT, Soballe K. The effect of pretreating morselized allograft bone with rhBMP-2 and/or pamidronate on the fixation of porous Ti and HA-coated implants. Biomaterials, 2008;29:2915-2922.
• 36. Shields LB, Raque GH, Glassman SD, et al. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine (Phila Pa 1976), 2006;31:542-547.
• 37. Holland TA, Mikos AG. Biodegradable polymeric scaffolds. Improvements in bone tissue engineering through controlled drug delivery. Adv Biochem Eng Biotechnol, 2006;102:161-185.
• 38. Doll B, Sfeir C, Winn S, Huard J, Hollinger J. Critical aspects of tissue-engineered therapy for bone regeneration. Crit Rev Eukaryot Gene Expr, 2001;11:173-198.
• 39. Rezwan K, Chen QZ, Blaker JJ, Boccaccini AR. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials, 2006;27:3413-3431.
• 40. Nie H, Wang CH. Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA. J Control Release, 2007;120:111-121.
• 41. Lattanzi W, Parrilla C, Fetoni A, et al. Ex vivo-transduced autologous skin fibroblasts expressing human Lim mineralization protein-3 efficiently form new bone in animal models. Gene Ther, 2008;15:1330-1343.
• 42. Caplan AI. Mesenchymal stem cells and gene therapy. Clin Orthop, 2000;379 Suppl. S67-S70.
• 43. Evans C. Gene therapy for the regeneration of bone. Injury, 2011;42:599-604.
• 44. Prockop DJ, Oh JY. Medical therapies with adult stem/progenitor cells (MSCs): a backward journey from dramatic results in vivo to the cellular and molecular explanations. J Cell Biochem, 2012;113:1460-1469.
• 45. Parrilla C, Saulnier N, Bernardini C, et al. Undifferentiated human adipose tissue-derived stromal cells induce mandibular bone healing in rats. Arch Otolaryngol Head Neck Surg, 2011;137:463-470.
• 46. Barba M, Cicione C, Bernardini C, et al. Spinal fusion in the next generation: gene and cell therapy approaches. ScientificWorldJournal, 2014;2014:406159.
• 47. Murray TM, Rao LG, Divieti P, Bringhurst FR. Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal ligands. Endocr Rev, 2005;26:78-113.
• 48. Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med, 2001;344:1434-1441.
• 49. Aspenberg P, Genant HK, Johansson T, et al. Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res, 2010;25:404-414.
• 50. Aspenberg P, Malouf J, Tarantino U, et al. Effects of Teriparatide compared with Risedronate on recovery after Pertrochanteric hip fracture: results of a randomized, active-controlled, double-blind clinical trial at 26 weeks. J Bone Joint Surg Am, 2016;98:1868-1878.
• 51. Bhandari M, Jin L, See K, et al. Does Teriparatide improve femoral neck fracture healing: results from a randomized placebo-controlled trial. Clin Orthop Relat Res, 2016;474:1234-1244.
• 52. Ha YC, Park YG, Nam KW, Kim SR. Trend in hip fracture incidence and mortality in Korea: a prospective cohort study from 2002 to 2011. J Korean Med Sci, 2015;30:483-488.
• 53. Hadji P, Zanchetta JR, Russo L, et al. The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures. Osteoporos Int, 2012;23:2141-2150.
• 54. Huang TW, Chuang PY, Lin SJ, et al. Teriparatide improves fracture healing and early functional recovery in treatment of osteoporotic intertrochanteric fractures. Medicine (Baltimore), 2016;95:e3626.
• 55. Johansson T. PTH 1-34 (teriparatide) may not improve healing in proximal humerus fractures: a randomized, controlled study of 40 patients. Acta Orthop, 2016;87:79-82.
• 56. Peichl P, Holzer LA, Maier R, Holzer G. Parathyroid hormone 1-84 accelerates fracture-healing in pubic bones of elderly osteoporotic women. J Bone Joint Surg Am, 2011;93:1583-1587.
• 57. Song HK, Kim SJ, Lee JH, Yang KH. Intermittent parathyroid hormone treatment for stimulation of callus formation in elderly patients. J Korean Fract Soc, 2012;25:295-299.
• 58. Tsuchie H, Miyakoshi N, Kasukawa Y, et al. The effect of teriparatide to alleviate pain and to prevent vertebral collapse after fresh osteoporotic vertebral fracture. J Bone Miner Metab, 2016;34:86-91.
• 59. Romano CL, Romano D, Logoluso N. Low-intensity pulsed ultrasound for the treatment of bone delayed union or nonunion: a review. Ultrasound Med Biol, 2009;35:529-536.
• 60. Rutten S, Nolte PA, Korstjens CM, van Duin MA, Klein-Nulend J. Low-intensity pulsed ultrasound increases bone volume, osteoid thickness and mineral apposition rate in the area of fracture healing in patients with a delayed union of the osteotomized fibula. Bone, 2008;43:348-354.
• 61. Brydone AS, Meek D, Maclaine S. Bone grafting, orthopaedic biomaterials, and the clinical need for bone engineering. Proc Inst Mech Eng H, 2010;224:1329-1343.

Figure & Data

REFERENCES

Citations

Citations to this article as recorded by  

• Calcium phosphate injection technique for treatment of distal radius fracture
  Dae-Geun Kim, Byung Hoon Kwack
  Medicine: Case Reports and Study Protocols.2021; 2(9): e0117.     CrossRef
• Experimental Study ofDohongsamul-tang(Taohongsiwu-tang) on Fracture Healing
  Hyun Ju Ha, Min-Seok Oh
  Journal of Korean Medicine Rehabilitation.2020; 30(2): 47.     CrossRef